4BC2
Crystal structure of human D-xylulokinase in complex with D-xylulose and adenosine diphosphate
4BC2 の概要
エントリーDOI | 10.2210/pdb4bc2/pdb |
関連するPDBエントリー | 4B6T 4B6Y 4BC3 4BC4 4BC5 |
分子名称 | XYLULOSE KINASE, ADENOSINE-5'-DIPHOSPHATE, D-XYLULOSE, ... (5 entities in total) |
機能のキーワード | transferase, glucuronate xylulokinase pathway, fggy carbohydrate kinase |
由来する生物種 | HOMO SAPIENS (HUMAN) |
タンパク質・核酸の鎖数 | 3 |
化学式量合計 | 179321.10 |
構造登録者 | |
主引用文献 | Bunker, R.D.,Bulloch, E.M.M.,Dickson, J.M.J.,Loomes, K.M.,Baker, E.N. Structure and Function of Human Xylulokinase, an Enzyme with Important Roles in Carbohydrate Metabolism J.Biol.Chem., 288:1643-, 2013 Cited by PubMed Abstract: D-Xylulokinase (XK; EC 2.7.1.17) catalyzes the ATP-dependent phosphorylation of d-xylulose (Xu) to produce xylulose 5-phosphate (Xu5P). In mammals, XK is the last enzyme in the glucuronate-xylulose pathway, active in the liver and kidneys, and is linked through its product Xu5P to the pentose-phosphate pathway. XK may play an important role in metabolic disease, given that Xu5P is a key regulator of glucose metabolism and lipogenesis. We have expressed the product of a putative human XK gene and identified it as the authentic human d-xylulokinase (hXK). NMR studies with a variety of sugars showed that hXK acts only on d-xylulose, and a coupled photometric assay established its key kinetic parameters as K(m)(Xu) = 24 ± 3 μm and k(cat) = 35 ± 5 s(-1). Crystal structures were determined for hXK, on its own and in complexes with Xu, ADP, and a fluorinated inhibitor. These reveal that hXK has a two-domain fold characteristic of the sugar kinase/hsp70/actin superfamily, with glycerol kinase as its closest relative. Xu binds to domain-I and ADP to domain-II, but in this open form of hXK they are 10 Å apart, implying that a large scale conformational change is required for catalysis. Xu binds in its linear keto-form, sandwiched between a Trp side chain and polar side chains that provide exquisite hydrogen bonding recognition. The hXK structure provides a basis for the design of specific inhibitors with which to probe its roles in sugar metabolism and metabolic disease. PubMed: 23179721DOI: 10.1074/JBC.M112.427997 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.97 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
